|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.1650 - 0.1650|
|52 Week Range||0.0308 - 0.2900|
|Beta (3Y Monthly)||3.37|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
CANAQUEST MEDICAL CORP (OTC Markets: “CANQF”) (the "Company" or “CanaQuest”) announces that it has won the Go Global Awards "Business of the Year – Category of Life Science”, presented by the International Trade Council. CanaQuest presented before a select judging panel and an audience of CEOs, investors and Government Ministers and Ambassadors. Additionally, CanaQuest filed an international patent on its first game-changing formulation, Mentabinol™, which protects THC users from negative psychotic side effects.
CANAQUEST MEDICAL CORP (OTC Markets: “CANQF”) (the "Company" or “CanaQuest”), a company developing unique health products and nutraceuticals utilizing cannabis and botanical oil extracts, has filed an International Cannabis/Botanical Patent which stems from its sponsored research program at Western University in London, Ontario, Canada. The use of marijuana is known to cause neuronal, molecular and neuropsychiatric side effects. As demonstrated in both clinical and pre-clinical research, THC is associated with a wide range of deleterious neuropsychiatric side-effects in both adolescent and adult users of MJ products.
PHOENIX, AZ / ACCESSWIRE / July 22, 2019 / The Stock Day Podcast welcomed CanaQuest Medical Corp (OTC PINK: CANQF) (“the Company”), a company engaged in the development of unique health products and nutraceuticals that utilize hemp, cannabis and algae oils. President and Co-Founder, Paul Ramsay, joined Stock Day host Everett Jolly. Jolly began the interview by asking Ramsay to provide some background information about the Company and their projects.